Aradigm Corporation announced changes to its board of directors, including the retirement of Frank Barker and the appointment of Lafmin Morgan and David Bell. Mr. Barker has been a director of Aradigm since 1999. Previously, Mr. Barker served in several positions at Johnson & Johnson Inc., including as a company group chairman.

Mr. Morgan and Mr. Bell are the designees of Grifols, S.A, and their appointment is in conjunction with the closing of the transaction between the company and Grifols announced on August 28, 2013. Lafmin Morgan is Corporate Vice President, Global Marketing for Grifols. Mr. Morgan leads the Global Marketing function for all Grifols Divisions, Bioscience, Hospital and Diagnostics.

He previously served as Grifols North American Vice President and General Manager for Pulmonary. Mr. Morgan joined Grifols in 2010. David Bell is Corporate Vice President of Grifols S.A. and General Counsel of Grifols Inc. Mr. Bell is responsible for all legal activities of Grifols' U.S. Operations.

Prior to joining Grifols in 2003, Mr. Bell was Vice President and General Counsel for Alpha Therapeutic Corporation and a partner in a law firm where he specialized in healthcare, pharmaceutical and biotechnology regulation and liability.